Emerging Treatment Options in Atopic Dermatitis: Topical Therapies
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Atopic dermatitis is a chronic inflammatory skin disorder affecting children and adults, with the majority presenting mild to moderate disease severity. The use of topical corticosteroids (TCSs) in combination with emollients has been the mainstay for treating mild to moderate atopic dermatitis since the 1950s, and as a supplement to systemic treatment in severe disease. However, while very effective, TCSs are often accompanied by poor adherence due to corticophobia (fear of using corticosteroids in patients or doctors), unwanted side effects, and in some cases insufficient clinical response. Topical calcineurin inhibitors (TCIs) are able to inhibit the activation of T-lymphocytes and thereby diminish inflammation. In some patients the use of TCIs has been limited due to a localized burning sensation on the first days of treatment, and also due to fear of other adverse effects. Consequently, there has been a need for the development of new topical products for atopic dermatitis. Novel topical therapies are in the pipeline and comprise both new doses and formulations of well-known pharmaceutical molecules and novel approaches targeting unique inflammatory pathways and mechanisms of disease, with a promise of higher efficacy and less harmful side effects. We review topical drugs in the pipeline for atopic dermatitis, and focus on those available in the clinicaltrials.gov database with a first received date from January 1, 2014 to May 31, 2017.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention
Simpson, E. L., Chalmers, J. R., Hanifin, J. M., Thomas, K. S., Cork, M. J., McLean, W. H. I., Brown, S. J., Chen, Z., Chen, Y., & Williams, H. C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.005 · Cited by 722
Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Ruzicka, T., Hanifin, J. M., Furue, M., Pulka, G., Mlynarczyk, I., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Yoshida, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606490 · Cited by 592
New insights into the epidemiology of childhood atopic dermatitis
Flohr, C., & Mann, J. (2014) · Allergy · doi:10.1111/all.12270 · Cited by 499
Grewe, S. R., Chan, S. C., & Hanifin, J. M. (1982) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(82)90008-2 · Cited by 230
Bissonnette, R., Poulin, Y., Zhou, Y., Tan, J., Hong, H. C., Webster, J., Ip, W., Tang, L., & Lyle, M. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10775.x · Cited by 92
Broeders, J. A., Ahmed Ali, U., & Fischer, G. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.02.1228 · Cited by 84
Furue, M., Kitahara, Y., Akama, H., Hojo, S., Hayashi, N., Nakagawa, H., & The JAPANESE E6005 Study Investigators (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12534 · Cited by 77
Cited by
Saeki, H., Baba, N., Oshiden, K., Abe, Y., & Tsubouchi, H. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15137 · Cited by 43
Revisiting Therapies for Atopic Dermatitis that Failed Clinical Trials
Agnihotri, G., & Lio, P. A. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00905-7 · Cited by 15
Légaré, S., Chagnon, M., Palijan, A., Kojok, K., & Bissonnette, R. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17743 · Cited by 6
Lee, Y.-S., Noh, D.-I., Lee, S.-J., Jeon, M.-H., Kim, Y.-R., Jang, W. J., & Lee, E.-W. (2025) · Journal of Applied Microbiology · doi:10.1093/jambio/lxaf256 · Cited by 3
Metadata
- Authors
- Nygaard, U., Deleuran, M., & Vestergaard, C.
- Venue
- Dermatology
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 233
- Issue
- 5
- Pages
- 333-343
- ISSN
- 1018-8665 (ISSN-L)
- 1421-9832
- OpenAlex
- W2771123080
- Cited by
- 99
- References
- 8
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging Treatment Options in Atopic Dermatitis: Topical Therapies. https://app.cochat.ai/papers/10.1159/000484407
- The paper
- Nygaard, U., Deleuran, M., & Vestergaard, C. (2017). Emerging Treatment Options in Atopic Dermatitis: Topical Therapies. Dermatology. https://doi.org/10.1159/000484407
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.